4-48500184-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015030.2(FRYL):āc.8629A>Gā(p.Ser2877Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000729 in 1,595,784 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015030.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FRYL | NM_015030.2 | c.8629A>G | p.Ser2877Gly | missense_variant | 63/64 | ENST00000358350.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FRYL | ENST00000358350.9 | c.8629A>G | p.Ser2877Gly | missense_variant | 63/64 | 5 | NM_015030.2 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000466 AC: 71AN: 152246Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000478 AC: 110AN: 230092Hom.: 0 AF XY: 0.000511 AC XY: 64AN XY: 125144
GnomAD4 exome AF: 0.000757 AC: 1093AN: 1443420Hom.: 1 Cov.: 30 AF XY: 0.000751 AC XY: 539AN XY: 717940
GnomAD4 genome AF: 0.000466 AC: 71AN: 152364Hom.: 0 Cov.: 32 AF XY: 0.000376 AC XY: 28AN XY: 74508
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 22, 2022 | The c.8629A>G (p.S2877G) alteration is located in exon 63 (coding exon 60) of the FRYL gene. This alteration results from a A to G substitution at nucleotide position 8629, causing the serine (S) at amino acid position 2877 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at